Vaccine Access, Certainty, and Innovation Act of 2015
Latest action · Feb 27, 2015 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 5, 2015
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Vaccine Access, Certainty, and Innovation Act of 2015
This bill requires the Centers for Disease Control and Prevention (CDC) to report on the process used by the Advisory Committee on Immunization Practices (ACIP) in making recommendations on vaccines.
The Department of Health and Human Services (HHS) must issue final guidance to facilitate the use of expedited pathways for the development and licensure of vaccines to prevent certain infectious diseases.
The Public Health Service Act is amended to require the CDC to provide a vaccine developer, upon request, with information on public health needs and priorities and certain epidemiological analyses or data.
The Federal Food, Drug, and Cosmetic Act is amended to require the Food and Drug Administration to establish a process for designating diseases as tropical diseases included in the priority review voucher program. The amount of the priority review user fee is set to the cost difference between a priority review and a non-priority review.
The National Institutes of Health must support or conduct activities to advance the development of vaccines and must report on vaccine research.
Within 60 business days of a recommendation by ACIP, HHS must determine whether to update Medicare coverage of vaccines.
The Government Accountability Office must report on the impact of Medicare and Medicaid reimbursement rates on vaccine access.
For purposes of calculating a medical loss ratio, the cost of a program to increase adult immunization is accounted for: (1) by a private health insurer as an activity that improves health care quality, and (2) by a Medicare Advantage or Part D plan under title XVIII (Medicare) of the Social Security Act as a medical loss.Cosponsors 1
Members who signed on, in the order they did. All signed on Feb 5, 2015.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NC | G. K. Butterfield | Original | Feb 5, 2015 |
Actions 4
Everything that happened, newest first.
- Feb 27, 2015Referred to the Subcommittee on Health.
- Feb 6, 2015Referred to the Subcommittee on Health.
- Feb 5, 2015Introduced in House
- Feb 5, 2015Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Administrative remedies
- Advisory bodies
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Government information and archives
- Government studies and investigations
- Health
- Health care costs and insurance
- Health care coverage and access
- Health information and medical records
- Immunology and vaccination
- Infectious and parasitic diseases
- Licensing and registrations
- Medicaid
- Medical research
- Medicare
- Public-private cooperation
- Trade restrictions
- User charges and fees
Text 1
Each version as it was printed, newest first.
- Feb 5, 2015Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.